Investigation of prognostic factors for second-line treatment with nivolumab for unresectable or recurrent esophageal cancer.Takashi Ogata,Nozomu Machida,Kosuke Takahashi,Kazuki Kano, Keisuke Koumori,Hayato Watanabe,Hirohito Fujikawa,Takanobu Yamada,Yasuhiro Inokuchi, Mitsuhiro Furuta,Yoshihiro Kaneta,Kei Hayashi, Ayaka Ishida,Takashi OshimaJOURNAL OF CLINICAL ONCOLOGY(2021)引用 2|浏览4暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要